United States · FDA National Drug Code directory
Benzonatate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-692_48b92534-e189-4b18-906f-8a4abcb776a4
- Product NDC
- 71610-692
- Form
- CAPSULE
- Composition / generic term
- Benzonatate
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170118
- Source listing expiry
- 20261231
Source-listed ingredients
- BENZONATATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE, PLASTIC (71610-692-30) · 71610-692-30
- 60 CAPSULE in 1 BOTTLE, PLASTIC (71610-692-53) · 71610-692-53
- 90 CAPSULE in 1 BOTTLE, PLASTIC (71610-692-60) · 71610-692-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →